Together with the company Dreem, the Sleep Research Society awarded Dr. Hoenig funds to study “Sleep as potential prognostic biomarker for longitudinal tau and amyloid burden in Alzheimer’s disease”. Dreem supported her project with the kind donation of 15 sleep monitoring headbands.
Multimodal Neuroimaging Cologne
van Eimeren – Lab